[go: up one dir, main page]

WO2009084020A3 - Topical composition comprising halobetasol and salicylic acid - Google Patents

Topical composition comprising halobetasol and salicylic acid Download PDF

Info

Publication number
WO2009084020A3
WO2009084020A3 PCT/IN2008/000670 IN2008000670W WO2009084020A3 WO 2009084020 A3 WO2009084020 A3 WO 2009084020A3 IN 2008000670 W IN2008000670 W IN 2008000670W WO 2009084020 A3 WO2009084020 A3 WO 2009084020A3
Authority
WO
WIPO (PCT)
Prior art keywords
halobetasol
salicylic acid
topical composition
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2008/000670
Other languages
French (fr)
Other versions
WO2009084020A2 (en
Inventor
Ulhas Rameshchandra Dhuppad
Vasant Sitaram Khachane
Nitin Babulal Bhamre
Akhilesh Dayanand Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glenmark Pharmaceuticals Ltd
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Publication of WO2009084020A2 publication Critical patent/WO2009084020A2/en
Publication of WO2009084020A3 publication Critical patent/WO2009084020A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to topical pharmaceutical compositions, their uses an methods of manufacturing. Specifically, the present invention relates to topical composition comprising combination of halobetasol and salicylic acid.
PCT/IN2008/000670 2007-10-18 2008-10-15 Topical composition comprising halobetasol and salicylic acid Ceased WO2009084020A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2074/MUM/2007 2007-10-18
IN2074MU2007 2007-10-18

Publications (2)

Publication Number Publication Date
WO2009084020A2 WO2009084020A2 (en) 2009-07-09
WO2009084020A3 true WO2009084020A3 (en) 2009-12-10

Family

ID=40824836

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000670 Ceased WO2009084020A2 (en) 2007-10-18 2008-10-15 Topical composition comprising halobetasol and salicylic acid

Country Status (2)

Country Link
BR (1) BRPI0805005A2 (en)
WO (1) WO2009084020A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
PL3310389T3 (en) 2015-06-18 2020-11-30 Bausch Health Ireland Limited TOPICAL COMPOSITIONS CONTAINING CORTICOSTEROIDS AND RETINOIDS FOR THE TREATMENT OF PSORIASIS
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
CN116421635A (en) * 2023-04-27 2023-07-14 小布悠(杭州)科技有限公司 Low-irritation antipruritic ball formula and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049835A1 (en) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. An acidified composition for topical treatment of nail and skin conditions
EP1332758A1 (en) * 2002-01-17 2003-08-06 Rifkin, Bruce Dermatological compositions comprising a corticosteroid and zinc pyrithione
US20040241099A1 (en) * 2003-05-28 2004-12-02 Popp Karl F. Foamable pharmaceutical compositions and methods for treating a disorder

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049835A1 (en) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. An acidified composition for topical treatment of nail and skin conditions
EP1332758A1 (en) * 2002-01-17 2003-08-06 Rifkin, Bruce Dermatological compositions comprising a corticosteroid and zinc pyrithione
US20040241099A1 (en) * 2003-05-28 2004-12-02 Popp Karl F. Foamable pharmaceutical compositions and methods for treating a disorder

Also Published As

Publication number Publication date
BRPI0805005A2 (en) 2009-08-25
WO2009084020A2 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
WO2012042371A3 (en) Pharmaceutical composition
IL204621A0 (en) Bicyclic - ?? - amino acid derivatives, compositions comprising the same and uses thereof
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
WO2012061290A3 (en) Pesticidal compositions and processes related thereto
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2010030598A3 (en) Pharmaceutical formulations comprising pemetrexed
WO2008089087A3 (en) Tablet-in-tablet compositions
WO2007095339A3 (en) Methods of manufacturing corticosteroid solutions
WO2011084553A3 (en) Compositions and uses of cis-1,1,1,4,4,4-hexafluoro-2-butene
WO2010043717A3 (en) Pharmaceutical topical compositions
WO2010118866A8 (en) Trehalulose-containing composition, its preparation and use
IL210549A (en) Substituted- quinoxaline-type bridged-piperidine compounds, compositions comprising them and uses thereof for the manufacture of medicaments
WO2009115084A3 (en) Pyrrolopyrimidine derivatives, and use thereof
WO2010141694A3 (en) Borinic compositions
WO2011141685A3 (en) Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof
WO2010092088A3 (en) Use of hydrophobin as a spreading agent
WO2008025819A3 (en) Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability
WO2011150457A3 (en) Haematopoietic-prostaglandin d2 synthase inhibitors
WO2011054741A3 (en) Crystalline complexes of 4-hydroxy benzoic acid and selected pesticides
WO2008142569A3 (en) Topical compositions containing magaldrate
WO2010046061A3 (en) Cosmetic and/or pharmaceutical formulations
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
WO2009094457A3 (en) Substituted benzhydrylethers
WO2009146202A3 (en) Transketalized compositions, synthesis, and applications
WO2008154234A3 (en) Extended release formulation of nevirapine

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08867935

Country of ref document: EP

Kind code of ref document: A2